The shares of an Indian IT-Software company involved in providing healthcare solutions through its care enablement platform are in focus after the company announces robust results. With Revenue growth of 17 percent Y-O-Y, the Net profits are up by 132 percent
The shares of Inventurus Knowledge Solutions Ltd, with a market capitalization of Rs. 28,501.73 crores on Friday. Its shares are trading at a CMP of Rs 1,661.20, against the previous closing price of Rs 1,653.90. The stock had hit a high of 5.1 percent Intraday
What Happened
Inventurus Knowledge Solutions Ltd, a company that provides healthcare solutions through its care enablement platform, announced its results for the Financial year ‘25. Its Revenue grew by 17 percent YoY from Rs 620 Crores in Q4FY24 to Rs 724 Crores in Q4FY25, and it has increased by close to 10.19 percent QoQ from Rs 657 Crores in Q3FY25 to Rs 724 Crores in Q4FY25.
Its Net Profit grew by 132 percent YoY from Rs. 63.6 Crores in Q4FY24 to Rs. 148 Crores in Q4FY25. The Net profits have grown by 13.84 percent QoQ from Rs. 130 Crores in Q3FY25 to Rs. 148 Crores in Q4FY25.
The company’s Earnings Before Interest, Depreciation, and Taxes (EBIDT) has also grown by 80 percent YOY from Rs 126 crores in Q4FY24 to Rs 226 crores in Q4FY25. Its EPS has also grown by 131 percent YOY from Rs. 3.72 in Q4FY24 to Rs. 8.61 in Q4FY25.
About the company
Inventurus Knowledge Solutions Ltd (IKS Health) is a healthcare services provider founded in 2006 and headquartered in India, with a strong operational footprint in the United States, Canada, and Australia. The company offers technology-enabled solutions that support healthcare organizations in delivering high-quality care while optimizing administrative and revenue functions. IKS Health’s core mission revolves around enhancing clinical outcomes, improving population health, and ensuring operational efficiency for healthcare providers.
Written by Likesh Babu S
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
